Specifically, the effects of BmKTX, a scorpion toxin, targeting KV1.3 have been studied as a possible treatment of AD and PD, as it could block microglial activation and thus reduce the neuroinflammation (Wang et al., 2020). The gene discussed is KCNA3; the disease is Parkinson disease.